Physician profile
Thomas Hinson
NPI 1538141767
$10,699.38
in general payments reported to CMS, 2019-2025
56 companies · $2,453 in 2025
The $2,453 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,313 · 2020: $792 · 2021: $1,309 · 2022: $1,309 · 2023: $1,596 · 2024: $1,928 · 2025: $2,453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,860 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,859.80 |
| Education | $117.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,484.11 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,405.55 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $1,256.88 | 2019-2025 | Airsupra, Fasenra, Tezspire |
| Regeneron Healthcare Solutions, INC. | $508.06 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $499.69 | 2022-2025 | Tyvaso, Tyvaso |
| Insmed, INC. | $447.41 | 2019-2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $432.48 | 2020-2025 | Prolastin-C Liquid, Xembify |
| Genzyme Corporation | $374.36 | 2019-2025 | |
| Verona Pharma, INC. | $351.35 | 2025 | Ohtuvayre |
| Mylan Specialty L.P. | $313.98 | 2019-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $307.16 | 2020-2025 | Glassia, Hyqvia |
| Merck Sharp & Dohme LLC | $302.59 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Philips North America LLC | $283.07 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Mallinckrodt Hospital Products INC. | $269.64 | 2020-2025 | Acthar |
| Gilead Sciences, INC. | $249.52 | 2019-2024 | Veklury |
Show all 56 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $164.78 | 2020-2023 | |
| Electromed, INC. | $146.31 | 2021-2024 | Smartvest |
| Inogen, INC. | $133.89 | 2023-2025 | Inogen |
| Actelion Pharmaceuticals US, INC. | $123.89 | 2021-2024 | Uptravi, Opsumit |
| Baxter Healthcare | $122.76 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System, Hillrom - Life 2000 Ventilation System |
| Pfizer INC. | $119.09 | 2019-2025 | |
| Harmony Biosciences LLC | $100.92 | 2025 | |
| Sanofi-Aventis U.S. LLC | $99.95 | 2024 | |
| Hospira, INC. | $95.45 | 2020-2023 | |
| Shionogi INC | $91.36 | 2021-2023 | Fetroja |
| Csl Behring | $76.23 | 2024 | Hizentra |
| Astellas Pharma US INC | $70.60 | 2019 | |
| Genentech USA, INC. | $69.42 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $55.64 | 2019-2021 | |
| Viatris Specialty LLC | $51.44 | 2025 | Yupelri |
| Amgen INC. | $50.94 | 2024-2025 | Tezspire, Tavneos |
| Mallinckrodt Enterprises LLC | $49.33 | 2019 | |
| Axsome Therapeutics, INC. | $40.77 | 2022-2023 | Sunosi |
| Tactile Systems Technology INC | $37.76 | 2021-2022 | |
| Ani Pharmaceuticals, INC. | $36.17 | 2022 | |
| Paratek Pharmaceuticals, INC. | $36.10 | 2020-2021 | |
| La Jolla Pharmaceutical Company | $36.02 | 2019-2023 | Giapreza |
| Vifor Pharma, INC. | $35.86 | 2025 | Zemaira |
| Bio Products Laboratory USA, INC. | $34.69 | 2019 | |
| Jazz Pharmaceuticals INC. | $29.60 | 2021 | |
| Covis Pharma Gmbh | $26.20 | 2021 | |
| Sunovion Pharmaceuticals INC. | $25.10 | 2020 | |
| Phadia US INC. | $24.53 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $23.37 | 2021 | |
| Tempus Ai, INC | $22.68 | 2025 | Xt Cdx |
| Advanced Respiratory, INC | $20.65 | 2021 | |
| Circassia INC. | $19.42 | 2019 | |
| 3b Medical, INC. | $19.20 | 2025 | Luna |
| Pulmonx Corporation | $18.46 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $17.64 | 2024 | Lumryz |
| Breathe Technologies, INC. | $17.21 | 2019 | |
| Lilly USA, LLC | $16.43 | 2025 | Zepbound |
| E.R. Squibb & Sons, L.L.C. | $14.53 | 2021 | |
| Allergan, INC. | $13.32 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.12 | 2019 | |
| Boston Scientific Corporation | $12.70 | 2023 | Exalt Model D |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Hinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.